Argenx, NL0010832176

argenx stock closes at EUR 844.60 on September 28, 2026, down 0.07 percent

Published on 09/28/2026 at 21:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

argenx shares closed at EUR 844.60 on Euronext Brussels on September 28, 2026, down 0.07 percent. The company recently announced board appointments and September investor conferences.

Fotorealistisches Laborpanorama: Wissenschaftler in weißen Kitteln begutachten leuchtende Antikörper-3D-Modelle auf Bildschirmen, Stahltische mit Laborgeräten im Hintergrund
Argenx NL0010832176 Forscher analysieren im modernen Biopharma-Labor leuchtende Antikörper-Strukturen auf großen Monitoren, Illustration mit AI erstellt.

argenx shares closed at EUR 844.60 on Euronext Brussels on September 28, 2026, down 0.07 percent from the previous close. The session was recorded at 3:35:06 p.m. UTC.

Board appointments announced

On September 17, 2026, argenx SE announced the results of its Extraordinary General Meeting of Shareholders and the appointment of Thomas M. Brakel and Khurem Farooq as non-executive directors to the company’s Board of Directors. The company said voting results and related meeting documents would be made available through its investor website. The announcement was issued by GlobeNewswire.

September investor events

Earlier in September, argenx announced that members of its management team would participate in the Wells Fargo 21st Annual Healthcare Conference on September 8 in Boston and the Morgan Stanley 24th Annual Global Healthcare Conference on September 14 in New York. The company said live webcasts and replays would be available through its investor website. The announcement was published by GlobeNewswire.

Disclaimer...

en | NL0010832176 | ARGENX | boerse | 70195000 | bgmi